Literature DB >> 1461948

In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology: relationship to dexamethasone suppression test results in patients.

D A Axelson1, P M Doraiswamy, O B Boyko, P Rodrigo Escalona, W M McDonald, J C Ritchie, L J Patterson, E H Ellinwood, C B Nemeroff, K R Krishnan.   

Abstract

The relationship between dexamethasone suppression test (DST) results and in vivo pituitary volume was studied in 24 psychiatric inpatients. The principles of systematic stereology were used to measure pituitary volume from 3-mm contiguous sagittal spin-echo magnetic resonance (MR) images of the brain. There was no correlation between pituitary volume and 3 p.m. or 10 p.m. postdexamethasone (post-DEX) plasma cortisol concentrations. However, when multiple regression analysis was performed to relate pituitary volume to gender, age, and post-DEX plasma cortisol concentrations, there was a significant relationship between pituitary volume and age, gender, and 10 p.m. post-DEX cortisol plasma concentration. This is the first study to demonstrate a method that directly measures, rather than estimates, in vivo pituitary volume. Furthermore, it suggests that activation of the hypothalamic-pituitary-adrenal axis in psychiatric patients, as manifested by elevated post-DEX cortisol concentrations, may influence pituitary volume.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1461948     DOI: 10.1016/0165-1781(92)90070-j

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  18 in total

1.  Choice of cross size in stereology--a cautionary note.

Authors:  J M Dickson; H M Weavers; N Mitchell; E M Winter; I D Wilkinson; E J R VanBeek; P D Griffiths
Journal:  Neuroradiology       Date:  2003-09-13       Impact factor: 2.804

Review 2.  The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Anne Maria Möller-Leimkühler; Giancarlo Giupponi; Paolo Girardi; Roberto Tatarelli; David Lester
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02-20       Impact factor: 5.270

Review 3.  Endocrine disturbances in depression.

Authors:  M A Tichomirowa; M E Keck; H J Schneider; M Paez-Pereda; U Renner; F Holsboer; G K Stalla
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

Review 4.  Basal ganglia volumetric studies in affective disorder: what did we learn in the last 15 years?

Authors:  R M Bonelli; H-P Kapfhammer; S S Pillay; D A Yurgelun-Todd
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

5.  Multilevel assessment of the neurobiological threat system in depressed adolescents: interplay between the limbic system and hypothalamic-pituitary-adrenal axis.

Authors:  Bonnie Klimes-Dougan; Lynn E Eberly; Melinda Westlund Schreiner; Patrick Kurkiewicz; Alaa Houri; Amanda Schlesinger; Kathleen M Thomas; Bryon A Mueller; Kelvin O Lim; Kathryn R Cullen
Journal:  Dev Psychopathol       Date:  2014-11

Review 6.  Neuroendocrine Stress System in Bipolar Disorder.

Authors:  Mario F Juruena; Anthony J Cleare; Allan H Young
Journal:  Curr Top Behav Neurosci       Date:  2021

7.  A Comparative Study of Pituitary Volume Variations in MRI in Acute Onset of Psychiatric Conditions.

Authors:  Brijesh Kumar Soni; Upendra Kumar Joish; Hirdesh Sahni; Raju A George; Rajeev Sivasankar; Rohit Aggarwal
Journal:  J Clin Diagn Res       Date:  2017-02-01

Review 8.  Risk factors for development of depression and psychosis. Glucocorticoid receptors and pituitary implications for treatment with antidepressant and glucocorticoids.

Authors:  Carmine M Pariante
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

9.  Pituitary volumes in relatives of bipolar patients: high-risk study.

Authors:  Tomas Hajek; Eva Gunde; Denise Bernier; Claire Slaney; Lukas Propper; Glenda Macqueen; Anne Duffy; Martin Alda
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

10.  Epigenetic Modulation of Mood Disorders.

Authors:  T Archer; M Oscar-Berman; K Blum; Ms Gold
Journal:  J Genet Syndr Gene Ther       Date:  2013-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.